Medications

Trial results of new drug for generalized myasthenia gravis

Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...

Diseases, Conditions, Syndromes

Protein study may be key to treating fibrotic diseases

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt ...

Diseases, Conditions, Syndromes

Black-legged ticks linked to encephalitis in New York state

The number of tick-borne illnesses reported to the U.S. Centers for Disease Control and Prevention is on the rise. Lyme disease leads the pack, with some 35,000 cases reported annually. In the Northeast, the black-legged ...

page 17 from 40